Serum Concentrations of Valproic Acid
- 1 December 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 7 (4) , 387-390
- https://doi.org/10.1097/00007691-198512000-00004
Abstract
The influence of valproate (VPA) dose, VPA preparation used, comedication (phenobarbital, phenytoin, carbamazepine) and factors such as age, weight, height, and sex on the concentration of VPA in serum was investigated. Nonlinear regression analysis showed that about 63% of the variance in the VPA morning concentrations of 259 inpatients could be explained by the following variables: dose, body weight, sex, and comedication. Age, height, and kind of preparation had no important influence on the VPA concentration. The relationship between dose and concentration of VPA is nonlinear, as the concentration does not increase proportionally with the dose but increases to a lesser extent. The serum concentration of VPA is clearly lower when the drug is given in combination with phenytoin (49.5%), carbamazepine (66.2%), or phenobarbital (76.3%) than when given alone (100%).This publication has 6 references indexed in Scilit:
- Plasma concentrations of sodium valproate: Their clinical valueAnnals of Neurology, 1983
- Sodium Valproate: Monotherapy and PolytherapyEpilepsia, 1982
- Clinical and pharmacokinetic observations on sodium valproate - A 5-year follow-up study in 100 children with epilepsyActa Neurologica Scandinavica, 1982
- Reduction of Steady‐State Valproate Levels by Other Antiepileptic DrugsEpilepsia, 1981
- Valproic AcidArchives of Neurology, 1979
- Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled StudyEpilepsia, 1979